Share This Article:

Results of Oncothermia Combined with Operation, Chemotherapy and Radiation Therapy for Primary, Recurrent and Metastatic Sarcoma

Full-Text HTML XML Download Download as PDF (Size:2412KB) PP. 157-168
DOI: 10.4236/crcm.2015.45033    2,437 Downloads   3,098 Views   Citations


Sarcomas are relatively rare malignancies; however, their huge variety and shortage of the effective therapies make this disease face huge challenge for oncology. It is recently shown that hyperthermia could be successfully applied even in high-risk cases in combination with the available gold-standard regiments. Our aim is to present various advanced cases treated with a new hyperthermia method, oncothermia, showing its advantages and feasibility to successfully treat highly advanced sarcomas with curative intent.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Jeung, T. , Ma, S. , Choi, J. , Yu, J. , Lee, S. and Lim, S. (2015) Results of Oncothermia Combined with Operation, Chemotherapy and Radiation Therapy for Primary, Recurrent and Metastatic Sarcoma. Case Reports in Clinical Medicine, 4, 157-168. doi: 10.4236/crcm.2015.45033.


[1] Surveillance, Epidemiology, and End Results (SEER) Research Data, Nov 2010 Sub (1973-2008) Total U.S., 1969-2009. National Cancer Institute, Surveillance Research Program, Cancer Statistics Branch, Released April 2011, Based on the November 2010 Submission.
[2] Fletcher, C.D.M., Krishnan, U.K. and Mertens, F. (2002) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. IRAC Press, Lyon, 298.
[3] Lahat, G., Lazar, A. and Lev, D. (2008) Sarcoma Epidemiology and Etiology: Potential Environmental and Genetic Factors. Surgical Clinics, 88, 451-481.
[4] Cheong, D., Gonzalez, R.J. and Zager, J.S. (2011) Strategies for Solutions in Sarcoma Management. Cancer Control, 18, 148-149.
[5] Riddle. N.D., Gonzalez, R.J., Bridge, J.A., Antonia, S. and Bui, M.M. (2011) A CD117 and CD34 Immunoreactive Sarcoma Masquerading as a Gastrointestinal Stromal Tumor: Diagnostic Pitfalls of Ancillary Studies of Sarcoma. Cancer Control, 18, 152-159.
[6] D’Angelo, S.P., Tap, W.D., Schwartz, G.K. and Carvajal, R.D. (2014) Sarcoma Immunotherapy: Past Approaches and Future Directions. Sarcoma, 2014, Article ID: 391967.
[7] Reed, D. and Altiok, S. (2011) Metastatic Soft Tissue Sarcoma Cemeotherapy: An Opportunity for Personalized Medicine. Cancer Control, 18, 188-195.
[8] National Cancer Institute (2010) Snapshots of Specific Types of Cancer. National Cancer Institute.
[9] Amankwah, E.K., Conley, A.P. and Reed, D.R. (2013) Epidemiology and Therapies for Metastatic Sarcoma. Clinical Epidemiology, 5, 147-162.
[10] Hohenberger, P. and Wysocki, W.M. (2008) Neoadjuvant Treatment of Locally Advanced Soft Tissue Sarcoma of the Limbs: Which Treatment to Choose? The Oncologist, 13, 175-186.
[11] Amankwah, E.K., Conley, A.P. and Reed, D.R. (2013) Epidemiology and Therapies for Metastatic Sarcoma. Clinical Epidemiology, 5, 147-162.
[12] Banerjee, R., Bandopadhyay, D. and Abilash, V.G. (2013) Epidemiology, Pathology, Types and Diagnosis of Soft Tissue Sarcoma: A Research Review. Asian Journal of Pharmaceutical and Clinical Research, 6, 18-25.
[13] Marulanda, G.A., Henderson, E.R., Johnson, D.A., Letson, G.D. and Cheong, D. (2008) Orthopedic Surgery Options for the Treatment of Primary Osteosarcoma. Cancer Control, 15, 13-20.
[14] Marulanda, G.A. and Letson, G.D. (2014) Controversies in Sarcoma.
[15] Esler, C.P. and Ashford, R.U. (2013) Radiotherapy Controversies in the Radical Treatment of Soft-Tissue Sarcomas of the Limb. European Oncology & Haematology, 9, 42-45.
[16] Fiegl, M., Schlemmer, M., Wndtner, C.M., Abdel-Rahman, S., Fahn, W. and Issels, R.D. (2004) Isofamide, Carboplatin and Etoposide (ICE) as Second-Line Regimen Alone and in Combination with Regional Hyperthermia Is Active in Chemo-Pre-Treated Advanced Soft Tissue Sarcoma of Adults. International Journal of Hyperthermia, 20, 661-670.
[17] Doi, O., Kodama, K., Tatsuta, M., Higashiyama, M., Aoki, Y., Kuriyama, K., et al. (1990) Effectiveness of Intrathoracic Chemothermotherapy for Malignant Pleurisy Due to Ewing’s Sarcoma: A Case Report. International Journal of Hyperthermia, 6, 963-969.
[18] Hiraoka, M., Nishimura, Y., Nagata, Y., Mitsumori, M., Okuno, Y., Li, P.Y., et al. (1995) Clinical Results of Thermoradiotherapy for Soft Tissue Tumors. International Journal of Hyperthermia, 11, 365-377.
[19] Egawa, S., Tsukiyama, I., Kajiura, Y., et al. (1993) Clinical Results of Hyperthermia Combined with Radiation or Chemotherapy for Soft-Tissue Sarcomas. In: Matsuda, T., Ed., Cancer Treatment by Hyperthermia, Radiation and Drugs, Taylor and Francis, London, 290-299.
[20] Otsuka, T., Yonezawa, M., Kamiyama, F., Matsushita, Y. and Matsui, N. (2001) Results of Surgery and Radio-Hyper-Thermo-Chemotherapy for Patients with Soft-Tissue Sarcoma. International Journal of Clinical Oncology, 6, 253-258.
[21] Leopold, K. and Issels, R.D. (2012) Thermoradiotherapy and Thermochemotherapy for Sarcomas. In: Seegenschmiedt, M.H., Fessenden, P. and Vernon, C.C., Eds., Thermo-Radiotherapy and Thermo-Chemotherapy, Vol. 2, Clinical Applications, Springer, Berlin, 147-158.
[22] Prosnitz, L.R., Maguire, P., Anderson, J.M., Scully, S.P., Harrelson, J.M., Jones, E.L., et al. (1999) The Treatment of High-Grade Soft Tissue Sarcomas with Preoperative Thermoradiotherapy. International Journal of Radiation Oncology*Biology*Physics, 45, 941-949.
[23] Issels, R.D., Bosse, D., Abdel-Rahman, S., Starck, M., Panzer, M., Jauch, K.W., et al. (1993) Preoperative Systemic Etioposide/Ifosfamide/Dox-Orubicin Chemotherapy Combined with Regional Hyperthermia in High-Risk Sarcoma: A Pilot Study. Cancer Chemotherapy and Pharmacology, 31, S233-S237.
[24] Issels, R.D., Abdel-Rahman, S., Wendtner, C.M., Falk, M.H., Kurze, V., Sauer, H., et al. (2001) Neoadjuvant Chemotherapy Combined with Regional Hyperhtermia (RHT) for Locally Advanced Primary or Recurrent High-Risk Adult Soft-Tissue Sarcomas (STS) of Adults: Long-Term Results of a Phase II Study. European Journal of Cancer, 37, 1599-1608.
[25] Schraffordt, K.H., Eggermont, A.M., Lienard, D., Kroon, B.B.R., Hoekstra, H.J., et al. (1998) Hyperthermic Isolated Limb Perfusion for the Treatment of Soft Tissue Sarcomas. Seminars in Surgical Oncology, 14, 210-214.<210::AID-SSU4>3.0.CO;2-B
[26] Kim, C.J., Puleo, C., Letson, G.D. and Reintgen, D. (2001) Hyperthermic Isolated Limb Perfusion for Extremity Sarcomas. Cancer Control: Journal of the Moffitt Cancer Center, 8, 269-273.
[27] Issels, R.D., Lindner, L.H., Verweij, J., Wust, P., Reichardt, P., Schem, B.-C., et al. (2010) Neo-Adjuvant Chemotherapy Alone or with Regional Hyperthermia for Localised High-Risk Soft-Tissue Sarcoma: A Randomised Phase 3 Multicentre Study. The Lancet Oncology, 11, 561-570.
[28] Wiedemann, G.J., Robins, H.I., Katschinski, D.M., Mentzel, M., D’Oleire, F., Kutz, M., et al. (1997) Systemic Hyperthermia and ICE Chemotherapy for Sarcoma Patients: Rationale and Clinical Status. Anticancer Research, 17, 2899-2902.
[29] Wiedemann, G.J., d’Oleire, F., Knop, E., Eleftheriadis, S., Bucsky, P., Feddersen, S., et al. (1994) Ifosfamide and Carboplatin Combined with 41.8 Degrees C Whole-Body Hyperthermia in Patients with Refractory Sarcoma and Malignant Teratoma. Cancer Research, 54, 5346-5350.
[30] Chen, W., Zhu, H., Zhang, L., Li, K.Q., Su, H.B., Jin, C.B., et al. (2010) Primary Bone Malignancy: Effective Treatmentwith High-Intensity Focused Ultrasound Ablation. Radiology, 255, 967-978.
[31] Hu, Y.C., Ji, J.T. and Lun, D.X. (2011) Intraoperative Microwave Inactivation In-Situ of Malignant Tumors in the Scapula. Orthopaedic Surgery, 4, 229-235.
[32] Szasz, A. (2013) “Quo Vadis” Oncologic Hyperthermia? Conference Papers in Medicine, 2013, Article ID: 201671.
[33] Roussakow, S. (2013) The History of Hyperthermia Rise and Decline. Conference Papers in Medicine, 2013, Article ID: 428027.
[34] Baronzio, G., Jackson, M., Lee, D. and Szasz, A. (2013) Editorial of the Conference of the International Clinical Hyperthermia Society 2012. Conference Papers in Medicine, 2013, Article ID: 690739.
[35] Szasz, A., Szasz, N. and Szasz, O. (2010) Oncothermia: Principles and Practices. Springer, Dordrecht, Heidelberg.
[36] Szasz, O. and Szasz, A. (2014) Oncothermia—Nano-Heating Paradigm. Journal of Cancer Science & Therapy, 6, 117-121.
[37] Meggyeshazi, N., Andocs, G., Balogh, L., Balla, P., Kiszner, G., Teleki, I., et al. (2014) DNA Fragmentation and Caspase-Independent Programmed Cell Death by Modulated Electrohyperthermia. Strahlentherapie und Onkologie, 190, 815-822.
[38] Andocs, G., Meggyeshazi, N., Balogh, L., Spisak, S., Maros, M.E., Balla, P., et al. (2014) Upregulation of Heat Shock Proteins and the Promotion of Damage-Associated Molecular Pattern Signals in a Colorectal Cancer Model by Modulated Electrohyperthermia. Cell Stress and Chaperones, 20, 37-46.
[39] Volovat, S.R., Volovat, C., Scripcariu, V., Lupascu, C. and Miron, L. (2014) The Results of Combination of Ifosfamid and Locoregional Hyperthermia (EHY 2000) in Patients with advanced Abdominal Soft-Tissue Sarcoma after Relapse of First Line Chemotherapy. Romanian Reports in Physics, 66, 175-181.

comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.